Mian Xi

19PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Radiation therapyEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 13, 2026
Continuation of First-Line Systemic Therapy with Progression-Directed Radiotherapy in Patients with Oligoprogressive Hepatocellular Carcinoma: A Multicenter, Single-Arm, Phase II Trial.

|Apr 10, 2026
Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002).

Baoqing Chen, Shiliang Liu, Yujia Zhu

|Mar 02, 2026
Longitudinal Plasma Metabolomics Guides Dynamic Risk Assessment and Dietary Modulation for Esophageal Squamous Cell Cancer Chemoimmunotherapy.

Zheng-Yu Qian, Yuqing Deng, Mian Xi

|Feb 02, 2026
Adding anti-PD-1 antibody to definitive chemoradiotherapy in elderly patients with esophageal squamous cell carcinoma: higher intensity does not equate to better outcomes.

Peiying Cen, Biqi Chen, Wenxi Zhou

|Jan 12, 2026
Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trials.

BaoQing Chen, Junying Chen, Sifen Wang

|Dec 19, 2025
Integrating lymphovascular invasion and ypTNM staging system for esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy and surgery: a multi-institutional analysis.

Shiliang Liu, Yujin Xu, Xufeng Guo

Pageof 4

Frequent Collaborators

7 joint publications

Baoqing Chen

6 joint publications

Shiliang Liu

6 joint publications

Qiaoqiao Li

3 joint publications

Yujia Zhu